New DrugRisks Info: Judge Will Allow Testimony Alleging NuvaRing Maker Failed to Warn of Risks

Share Article

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today

News Image
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact DrugRisks or speak with a lawyer about their legal rights as soon as possible.

The birth control safety advocates at DrugRisks.com are announcing updated news on the site for women who have used the vaginal ring contraceptive NuvaRing. A judge recently signed an order allowing expert testimony alleging the maker of the drug failed to provide proper alleged warning of risks***.

The goal of DrugRisks is to improve the safety of popular prescription drugs like NuvaRing by providing patients with the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.

Health experts have warned that contraceptive rings like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal rings could relate to a 2.5 to 3-fold increased risk of blood clots*.

Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel, who presides over the federal cases, recently scheduled the start of the first NuvaRing trial for October 21, 2013**.

Now, DrugRisk has learned that Judge Sippel entered an order on March 5th which will allow testimony by expert witnesses alleging the makers of the device, Organon and Merck, concealed the risk of estrogen bursts to the FDA and failed to give label warnings about variable estrogen levels, which could contribute to an alleged blood clot risk***.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism and believes it may be related to NuvaRing use is urged to contact DrugRisks or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions patients to seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to NuvaRing and other devices, or to speak with a lawyer.

*nejm.org/doi/full/10.1056/NEJMoa1111840
**http://cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf
***mo.findacase.com/research/wfrmDocViewer.aspx/xq/fac.20130305_0000431.EMO.htm/qx

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website